136 related articles for article (PubMed ID: 13406113)
1. The effects of reserpine on psychotic patients of varying degrees of illness: a pilot study.
HAUCK P; PHILIPS H; ARMSTRONG R
J Clin Psychol; 1957 Apr; 13(2):188-90. PubMed ID: 13406113
[No Abstract] [Full Text] [Related]
2. The place of reserpine in the treatment of the chronic psychotic patient.
GORE CP; EGAN GP; WALTON D
Am J Psychiatry; 1957 Oct; 114(4):333-7. PubMed ID: 13458497
[No Abstract] [Full Text] [Related]
3. [Reserpine in psychiatric treatment].
BRACHA S; HES JP
Harefuah; 1956 Sep; 51(5):101-6. PubMed ID: 13375974
[No Abstract] [Full Text] [Related]
4. Comparison of clinical effects of chlorpromazine and reserpine in psychotic patients.
GOLDMAN D
Am J Med Sci; 1957 Feb; 233(2):137-44. PubMed ID: 13394590
[No Abstract] [Full Text] [Related]
5. Reserpine in acute psychotic states; report of a controlled study.
HICKERSON GX; SWAIN JM; TEMPEY FW
J Nerv Ment Dis; 1956 Dec; 124(6):614-7. PubMed ID: 13476191
[No Abstract] [Full Text] [Related]
6. The management of side effects of chlorpromazine and reserpine.
SAINZ AA
Psychiatr Q; 1956 Oct; 30(4):647-53. PubMed ID: 13400975
[No Abstract] [Full Text] [Related]
7. The use of reserpine in chronic psychotic patients: a controlled trial.
WING L
J Ment Sci; 1956 Jul; 102(428):530-41. PubMed ID: 13367768
[No Abstract] [Full Text] [Related]
8. [Reserpine in therapy of psychoses].
LYAGER T; RØNTORP PS
Ugeskr Laeger; 1955 May; 117(19):603-10. PubMed ID: 13247445
[No Abstract] [Full Text] [Related]
9. Evaluation of reserpine and methyl phenidylacetate used separately and in combination in chronic psychotic patients.
FOX WW; MCPHEETERS H
J Ky State Med Assoc; 1956 Sep; 54(9):785-91. PubMed ID: 13357869
[No Abstract] [Full Text] [Related]
10. Use of reserpine in disturbed psychotic patients.
BARSA JA; KLINE NS
Am J Psychiatry; 1956 Mar; 112(9):684-91. PubMed ID: 13292559
[No Abstract] [Full Text] [Related]
11. Reserpine and chronic psychosis: two-year outcome in a treatment group.
FERGUSON RS
J Ment Sci; 1959 Jan; 105(438):251-5. PubMed ID: 13641979
[No Abstract] [Full Text] [Related]
12. Chlorpromazine and reserpine in the treatment of psychoses.
KINROSS-WRIGHT V
Ann N Y Acad Sci; 1955 Apr; 61(1):174-82. PubMed ID: 14377285
[No Abstract] [Full Text] [Related]
13. Effects of tranquilizers upon pathological activity in psychotic patients.
CUTLER RP; MONROE JJ; ANDERSON TE
AMA Arch Neurol Psychiatry; 1957 Jul; 78(1):61-8. PubMed ID: 13434527
[No Abstract] [Full Text] [Related]
14. The use of chlorpromazine and of serpasil in the treatment of psychotic patients.
LEWIS LF
Caribb Med J; 1956; 18(1-2):51-66. PubMed ID: 13374729
[No Abstract] [Full Text] [Related]
15. Reserpine in the treatment of neuropsychiatric disorders.
CLOUGH PW
Ann Intern Med; 1955 Sep; 43(3):632-7. PubMed ID: 13249245
[No Abstract] [Full Text] [Related]
16. Reserpine in hospitalized psychotics; a controlled study on chronically disturbed women.
ARNOLD AL; FREEMAN H
AMA Arch Neurol Psychiatry; 1956 Sep; 76(3):281-5. PubMed ID: 13354049
[No Abstract] [Full Text] [Related]
17. Physiological studies after continuous serpasil therapy over 18 months.
FOGEL EJ
Dis Nerv Syst; 1956 Oct; 17(10):322-3. PubMed ID: 13365515
[No Abstract] [Full Text] [Related]
18. Combined reserpine-chlorpromazine therapy in disturbed psychotics.
BARSA JA; KLINE NS
Am J Psychiatry; 1955 Apr; 111(10):780. PubMed ID: 14361766
[No Abstract] [Full Text] [Related]
19. Results with chlorpromazine and reserpine on chronically nude, untidy, destructive and combative patients: their sustained improvement after discharge with continued medication.
TUTEUR W; STILLER R; WHITEHILL O; LEPSON D
Am J Psychiatry; 1956 Mar; 112(9):741. PubMed ID: 13292568
[No Abstract] [Full Text] [Related]
20. [Incidence and causes of activity changes of alkaline serum phosphatase during drug therapy of psychoses].
HIPPIUS H; KANIG K; SELBACH H
Klin Wochenschr; 1958 May; 36(9):417-24. PubMed ID: 13550849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
